Blockade of radiocontrast-lnduced nephrotoxicity by the endothelin receptor antagonist, SB 209670

Nephron

Volumn 72, Issue 4, 1996, Pages 629-636

  Brooks, David P ^a   De Palma, Dennis ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Endothelin; Endothelin receptors; Nephrotoxicity; Radiocontrast; Renal failure

Indexed keywords

3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; DIATRIZOATE; ENDOTHELIN; ENDOTHELIN RECEPTOR ANTAGONIST; INDOMETACIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIURESIS; FEMALE; INTRAARTERIAL DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; MALE; NATRIURESIS; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; VASOCONSTRICTION;

ANIMALS; BLOOD PRESSURE; CONTRAST MEDIA; DIURESIS; DOGS; FEMALE; GLOMERULAR FILTRATION RATE; INDANS; KIDNEY DISEASES; MALE; NATRIURESIS; RECEPTORS, ENDOTHELIN; RENAL CIRCULATION; VASCULAR RESISTANCE;

EID: 0029876933     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000188951     Document Type: Article

References (36)

1. Sherwood T, Lavender JP: Does renal blood flow rise or fall in response to diatrizoate? Invest Radiol 1969:4:327-334.
2. Launer LB. Davidson AJ: Renal hemodynamic effects of contrast media. Invest Radiol 1968:3: 310.
3. Forrest JB. Howards SS. Gillenwatcr JY: Osmotic effects of intravenous contrast agents on renal function. J Urol 1980;125:147-150.
4. Cantley LG, Spokes K. Clark B. McMahon EG. Carter J. Epstein FH: Role of endothelin and prostaglandins in radiocontrast-induced renal artery constriction. Kidney Int 1993:44:1217-1223.
5. Yanagisawa M. Kurihara H. Kimura S. To-mobe Y. Kobayashi M. Mitsui Y. Yazaki Y, Goto K. Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988:332:411-415.
6. Goetz KL. Wang BC. Madwed JB. Zhu JL. Leadley RJ: Cardiovascular, renal and endocrine responses to intravenous endothelin in conscious dogs. Am J Physiol 1988:255: R1064-R1068.
7. DeNucci G, Thomas R. D'Orleans-Jliste P. An-tunes E. Walder C. Warner TD, Vaue JR: Pressor effects of circulating endothelin arc limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988:85:9797-9800.
8. Arai H. Hori S. Aramori L, Ohkubc H. Nakani-shi S: Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990: 348:730-732.
9. Sakurai T. Yanagisawa M, Takuwa Y, Miyazaki H. Kimura S. Goto K. Masaki T: Cloning of a cDNA encoding a nonisopeptide-selectivc subtype of an endothelin receptor. Nature 1990:348:732-735.
10. Kon V. Yoshioka T. Fogo A. Ichikawa I: Glomerular actions of endothelin in vivo. J Clin Invest 1989:83:162-167.
11. Gellai M. Jugus M. Fletcher T. De Wolf R. Nambi P: Reversal of postischcmic ARF with a selective ET, receptor antagonist in the rat. J Clin Invest 1994;93:900-906.
12. Gellai M. Jugus M. Fletcher TA. Nambi P. Brooks DP. Ohlstcin EH. Elliott JD. Gleason J. Ruffolo RR Jr: The endothelin receptor antagonist. βPSB 209670. reverses ischemia-induced acute renal failure in the rat. FASEB J 1994;8:A260.
13. Brooks DP. DcPalma PD. Gellai M. Nambi P. Ohlstein EH. Elliott JD. Gleason J. Ruffolo RR Jr: Nonpeptide endothelin receptor antagonists. III. Effect of SB 209670 and BQ123 on acute renal failure in anesthetized dogs. J Pharmacol ExpTher 1994;271:769-775.
14. Brooks DP. DcPalma PD. Gellai M. Nambi P, Ohlstein E. Elliott J. Gleason J. Ruffolo RR Jr: Effect of the endothelin receptor antagonists, (±)-SB 209670 and BQ123. on ischemia-induced acute renal failure in the dog. FASEB J 1994;8:A585.
15. Kon V, Sugiura M, Inagami T. Harvic BR, Ichikawa L. Hoover RL: Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int 1990:37:1487-1491.
16. Nambi P. Pullen M. Contino LC. Brooks DP: Upregulation of renal endothelin receptors in rats with cyclosporine A-induced nephrotoxicity. Eur J Pharmacol 1990; 187:113-116.
17. Brooks DP. Ohlstein EH, Contino LC. Storcr B. Pullen M. Caltabiano M. Nambi P: Effect of nifedipine on cyclosporine A-induced nephrotoxicity. urinary endothelin excretion and renal endothelin receptor number. Eur J Pharmacol 1991:194:115-117.
18. Brooks DP. Contino LC. Storer B, Ohlstein EH: Increased endothelin excretion in rats with renal failure induced by partial nephrectomy. Br J Pharmacol 1991;104:987-989.
19. Benigni A. Perico N. Gaspari F. Zoja C, Belliz-zi L. Gabanelli M. Remuzzi G: Increased renal endothelin production in rats with reduced renal mass. Am J Physiol 1991:260:F331 -F339.
20. Bcnigni A. Zoja C. Coma D. Orisio S. Longar-etti L. Bertani T. Remuzzi G: A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. Kidney Int 1993;44:440-444.
21. Clark BA, Hcyman SN. Spokes K. West C. Epstein FH: Rise in plasma endothelin produced by radiocontrast agents. J Am Soc Nephrol 1990:4:412.
22. Margulies KB. Hildebrand FL, Hcublein DM, Burnett JC Jr: Radiocontrast increases plasma and urinary endothelin. J Am Soc Nephrol 1991;2:1041-1045.
23. Gurkowski L, MacDougall M, Wiegmann T: Radiocontrast induces renal endothelin production and excretion in humans. Clin Res 1993:4 LA255.
24. Kohan DE. Padilla E: Osmolar regulation of cndothelin-1 production by rat inner medullary collecting duct. J Clin Invest 1993:91:1235-1240.
25. Schramek H, Gstraunthaler G. Willingcr CC. Pfaller W: Hyperosmolality regulates endothelin release by Madin-Darby canine kidney cells. J Am Soc Nephrol 1993;4:206-213.
26. Yang T. Terada Y. Nonguchi H, Ujiie K, Tomita K. Marumo F: Effect of hyperosmolality on production and mRNA expression of ET-1 in inner medullary collecting duct. Am J Physiol 1993:264:F684-F689.
27. Fuhr J, Kaczmarkczyk J. Kruttgen CD: Eine einfache colorimetrische Methode zur Inulinbestimmung. Klin Wochenschr 1955:33:729-730.
28. Elshourbagy NA, Korman DR. Wu H-L. Sylvester DR, Lee JA. Nuthulaganti P. Bergsma DJ. Kumar CS. Nambi P: Molecular characterization and regulation of the human endothelin receptors. J Biol Chem 1993:268:3873-3879.
29. Nambi P, Wu H-L. Pullen M, Elshourbagy N, Ohlstcin EH, Brooks DP. Elliott JD. Gleason J. Ruffolo RR Jr: Non-peptide endothelin receptor antagonists. I. Effects on binding and signal transduction on human ETJ and ETu receptors. J Pharmacol Exp Ther 1994:271:755-761.
30. Ohlstcin E, Nambi P. Douglas SA. Edwards RM. Gellai M. Lago A. Leber JD. Cousins RD, Gao A. Frazce JS. Peishoff CE, Bean JW, Eggleston DS, Elshourbagy NA. Kumar C. Lee JA, Brooks DP. Ruffolo RR Jr. Feuerstein G, Weinstock J, Gleason JG, Elliott JD: A rationally designed potent nonpeptide endothelin receptor antagonist. Proc Natl Acad Sei USA 1994;91:8052-8056.
31. Brooks DP, DcPalma PD, Pullen M. Nambi P: Characterization of canine renal endothelin receptor subtypes and their function. J Pharmacol ExpTher 1994:268:1091-1097.
32. Katlberg RW, Morris TW, Schulman G. Caldi-cott WJH, Boylan LM. Foley MJ. Spataro RF. Fischer HW: Reactions to intravenous contrast media. Radiology 1983, 147:331-334.
33. Arend LJ, Bakris GL, Burnett JC Jr. Mcgcrian C, Spiclman WS: Role for intrarenal adenosine in the renal hemodynamic response to contrast media. J Lab Clin Med 1987;110:406-411.
34. Arakawa K. Suzuki H, Naitoh M. Matsumoto A. Ichihara A, Oka K. Saruta T: Adenosine A1-rcceptor antagonist. KW3902. completely prevents non-ionic radiocontrast-induced nephropathy in conscious dogs with renal insuffi-cency. J Am Soc Nephrol 1994:3:916.
35. Schrermann J, Weihprect H, Briggs J: Inhibition of tubuloglomerular feedback during adenosine-1-receptor blockade. Am J Physiol 1990; 258:F553-F561.
36. Caldicott WJH, Hollenberg NK. Abrams HL: Characteristics of response of renal vascular bed to contrast media: Evidence of vasoconstriction induced by renin-angiotensin system. Invest Radiol 1970:5:539-547.